文献速递外周动脉疾病

戒烟干预在外周动脉疾病患者中疗效的随机对照试验荟萃分析

A meta-analysis of randomized controlled trials evaluating the efficacy of smoking cessation interventions in people with peripheral artery disease.
PubMed 文献 · J Vasc Surg · 2021-09-30

该荟萃分析纳入6项随机临床试验、共558名吸烟的外周动脉疾病患者,评估医生建议、行为咨询及尼古丁替代/伐尼克兰等干预的戒烟效果。结果显示干预总体未显著提高戒烟率(RR 1.48,95%CI 0.84-2.61),异质性低(I2=20%),偏倚风险高至低不等,结论需进一步研究有效干预。

要点

  • 现有戒烟干预在外周动脉疾病患者中未显著提高戒烟率。
  • 合并风险比1.48(95%CI 0.84-2.61),研究间异质性低。
  • 需开发并测试能有效帮助PAD吸烟者戒烟的新干预。

核心结论

  • 总体而言,既往测试的戒烟干预未能有效帮助外周动脉疾病患者戒烟。

研究设计与样本

  • 系统检索公共数据库的随机临床试验,纳入测试干预项目对PAD当前吸烟者戒烟效果的试验。
  • 共纳入6项随机临床试验,合计558名吸烟的PAD患者。
  • 干预包括医生建议、专家面对面或电话行为咨询、提供尼古丁替代疗法和/或伐尼克兰。
  • 主要结局为随访结束时戒烟,采用随机效应模型进行荟萃分析,报告风险比及95%置信区间。

主要发现

  • 荟萃分析显示干预总体未显著增加戒烟机会(风险比1.48,95%CI 0.84-2.61)。
  • 研究间异质性低(I2=20%),敏感性分析结果稳健。
  • 偏倚风险:1项研究高、3项中等、2项低。
  • 漏斗图提示发表偏倚风险低。

临床怎么用

  • 当前证据不支持将已测试的戒烟干预常规用于PAD患者戒烟并预期显著效果。
  • 临床仍需鼓励戒烟,但应认识到现有干预效果有限,可考虑个体化策略。

局限性

  • 纳入研究数量少(6项),总样本量558例。
  • 多数研究存在中等至高偏倚风险。
  • 干预类型异质,无法确定特定干预的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This review aimed to systematically pool evidence from randomized clinical trials on the efficacy of interventions in assisting smoking cessation in participants with peripheral artery disease (PAD). METHODS: Publicly available databases were searched for randomized clinical trials testing the effect of interventional programs in achieving smoking cessation in participants with PAD who were current smokers. The primary outcome was smoking cessation at the end of follow-up. Meta-analyses were performed using random effect models and reported as risk ratios and 95% confidence intervals. Risk of bias and publication bias were assessed using a modified version of the Cochrane Collaboration's tool and funnel plots, respectively. RESULTS: Six randomized clinical trials testing smoking cessation programs comprising physician advice, behavioral counselling from an expert delivered in-person or over the telephone, and the provision of nicotine replacement therapy and/or varenicline in 558 smokers with PAD were included. A meta-analysis suggested that, overall, these interventions did not significantly increase the chance of quitting smoking (risk ratio, 1.48; 95% confidence interval, 0.84-2.61), with low heterogeneity between studies (I2 = 20%), which were robust in sensitivity analyses. Risk of bias was high, moderate, and low in one, three, and two studies respectively. A funnel plot suggested a low risk of publication bias. CONCLUSIONS: Overall, previously tested smoking cessation interventions have not been effective in achieving smoking cessation in people with PAD. Further research is needed to develop and test interventions that can effectively help current smokers with PAD to quit.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Thanigaimani S, Drovandi A, Golledge J, et al. A meta-analysis of randomized controlled trials evaluating the efficacy of smoking cessation interventions in people with peripheral artery disease. J Vasc Surg. 2021. PMID: 34600029. doi:10.1016/j.jvs.2021.07.248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。